Friday, September 2, 2016

BRIEF-U.S. FDA cancels Dynavax's Nov advisory committee meeting

* U.S. FDA says November advisory committee meeting to

discuss hepatitis B vaccine from Dynavax Technologies Corp has

been canceled

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)